CQS
TEVA icon

Credential Qtrade Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Credential Qtrade Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-130
Closed -$1.15K – 416
2023
Q1 		$1.15K Buy
+130
New +$1.28K ﹤0.01% 383

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credential Qtrade Securities's TEVA Position: Q2 2023 in Review

Credential Qtrade Securities sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 130 shares — an estimated $1.15K sold.

Credential Qtrade Securities first reported a position in TEVA in Q1 2023 and held it in 1 quarter. The position peaked at $1.15K in Q1 2023. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Credential Qtrade Securities reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Credential Qtrade Securities sold 130 Teva Pharmaceuticals shares in Q2 2023, an estimated $1.15K.
  • Credential Qtrade Securities first reported a position in Teva Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Credential Qtrade Securities's Teva Pharmaceuticals position peaked at $1.15K in Q1 2023.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Credential Qtrade Securities's 13F filing for Q2 2023, filed 21 Jul 2025.